论文信息 - Comment on "Shadows Behind Using Simple Risk Models in Selection of HCC Patients for LT".

Comment on "Shadows Behind Using Simple Risk Models in Selection of HCC Patients for LT".

Departments and Institutions: 1. Liver Transplant and Hepatology Unit. Hospital Universitario Austral, School of Biomedical Science, Austral University. Pilar, Argentina. 2. Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina. 3. Department of Liver Surgery, Henri-Mondor Hospital, APHP, Paris-Est University, Créteil, France. 4. Hepato-Biliary Center, Paul Brousse Hospital, Paris, France. 5. Department of Hepatology, Medical Liver Transplant Unit, Henri-Mondor Hospital, APHP, Paris-Est University, Créteil, France.

[1] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[2] J. Twisk,et al. Ignoring competing events in the analysis of survival data may lead to biased results: a non-mathematical illustration of competing risk analysis. , 2020, Journal of clinical epidemiology.

[3] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[4] F. Roudot-thoraval,et al. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. , 2017, Journal of hepatology.

[5] F. Roudot-thoraval,et al. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.

[6] K. Zieniewicz,et al. Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation , 2018, Annals of surgery.

[7] Roger Newson,et al. Comparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D , 2010 .

[8] Jia Fan,et al. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. , 2018, Gastroenterology.